QbD is not a checklist. It is a development strategy.
Quality by Design works best when teams can identify critical risks early, design around those risks, and make science-based decisions before scale-up and validation. Programs often struggle not because QbD is flawed, but because decision-ready data is not available early enough.
Where DoE Often Loses Efficiency
Design of Experiments is powerful when the design space is meaningful. In practice, teams can lose time and material when ranges are too broad, interactions are hidden by noise, or experimental plans are not grounded in material and compaction behavior from the start.
When mechanistic understanding is delayed, DoE becomes reactive. The result is often extra experiments, less interpretable outcomes, and slower progression to confident decisions.
How TaBlitz Strengthens Existing QbD and DoE Workflows
TaBlitz supports early quantitative linking of material attributes and formulation properties to compaction behavior while decisions are still high-impact. This helps teams build stronger development logic before committing to large experimental programs.
Identify critical material attributes that influence tabletability, compactability, and compressibility.
Assess manufacturability risk, including sensitivity to pressure, strain rate, and variability, prior to formal DoE execution.
Target DoE responses that are decision-relevant, such as operating window robustness and mechanical performance.
Reduce unnecessary experiments by constraining the design space with mechanistic insight.
Built for Modern Development Models
Whether teams are operating in large pharmaceutical organizations or distributed development models, TaBlitz supports structured data generation, clearer cross-functional communication, and continuity from early formulation through scale-up.
Next Step
If your goal is better predictability and fewer late-stage surprises, we can walk through practical ways to integrate this approach into your current workflow.